Open original FDA record ↗Recall record
- FDA identifier
- Z-1310-2022
- Company in FDA record
- Haemonetics Corporation
- FDA record creation date
- Jun 30, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.
Source facts
- Action
- On April 26, 2022, affected customers were provided with a recall letter via email. Customers may continue to use the TEG 5000 Functional Fibrinogen reagent with the current IFU in conjunction with the letter which reflects the updated ranges. Haemonetics will provide a revision to the IFU. Additionally, customers using Functional Fibrinogen reagent are being reminded to continue to follow the instructions in the current Instructions for Use (118474-MULTI (XX)), which state - Results from the TEG analyzer should not be the sole basis for a patient diagnosis TEG analyzer results should be considered along with a clinical assessment of the patient's condition and other coagulation laboratory tests.
- Initiated
- 2022-04-26
- Root cause
- Other
- Terminated
- 2024-03-15
- Distribution
- Domestic distribution US Nationwide.
- Recall number
- Z-1310-2022
- Recall status
- Terminated
- CDRH record ID
- 194131
- FDA record created
- 2022-06-30
- Recall event number
- 90323